Adipose Tissue, Natriuretic Peptides, and HFpEF: Clinical Implications of the Obesity Paradox

<b>Introduction</b>: Adipose tissue (AT) is increasingly recognized as an active endocrine and immunological organ involved in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). Dysfunctional AT, particularly visceral, promotes chronic low-grade inflammation,...

書誌詳細
出版年:	Biomedicines
主要な著者:	Michał Maksymilian Wilk, Piotr Gajewski
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2026-06-01
主題:	HFpEF obesity adipose tissue natriuretic peptides
オンライン･アクセス:	https://www.mdpi.com/2227-9059/14/6/1305

類似資料

Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
著者:: Paolo Morfino, 等
出版事項: (2022-08-01)

HFpEF Diagnosis: A Challenge in CKD with Current Algorithms
著者:: Anca E. Stefan, 等
出版事項: (2026-06-01)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
著者:: Norman Mangner, 等
出版事項: (2023-10-01)

Specific targeting of adipose tissue metabolism is superior to caloric restriction in treating obesity-related HFpEF
著者:: Simon Sedej, 等
出版事項: (2025-07-01)

Strengths and limitations of HFpEF probability scores in the era of precision medicine
著者:: Michał Wilk, 等
出版事項: (2026-04-01)

Correction: Strengths and limitations of HFpEF probability scores in the era of precision medicine
著者:: Michał Wilk, 等
出版事項: (2026-06-01)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
著者:: Leonie Grossekettler, 等
出版事項: (2020-05-01)

The Possible Role of Rosuvastatin Therapy in HFpEF Patients—A Preliminary Report
著者:: Tomasz Urbanowicz, 等
出版事項: (2024-11-01)

Hepatocyte growth factor and B-type natriuretic peptide as independent predictors of mortality in HFpEF patients
著者:: Hou-liang Chen, 等
出版事項: (2025-02-01)

Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF
著者:: Lingyun Luo, 等
出版事項: (2025-04-01)

The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
著者:: Shenghua Zhou, 等
出版事項: (2025-03-01)

Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
著者:: Albin Oh, 等
出版事項: (2019-08-01)

Integrated proteomic and metabolomic profiling reveals novel insights on the inflammation and immune response in HFpEF
著者:: Muyashaer Abudurexiti, 等
出版事項: (2024-07-01)

Identification of noval diagnostic biomarker for HFpEF based on proteomics and machine learning
著者:: Muyashaer Abudurexiti, 等
出版事項: (2025-04-01)

Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
著者:: Sören J. Backhaus, 等
出版事項: (2022-12-01)

Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF
著者:: Karsten Piatek, 等
出版事項: (2022-12-01)

Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study
著者:: Jie Liu, 等
出版事項: (2023-03-01)

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
著者:: Marieke R. Wilke, 等
出版事項: (2023-04-01)

A New Medical Decision Support System for Diagnosing HFrEF and HFpEF Using ECG and Machine Learning Techniques
著者:: Pinar Ozen Kavas, 等
出版事項: (2022-01-01)

Incidence and causal association of functional atrial mitral regurgitation in HFpEF
著者:: Nikos T. Kouris, 等
出版事項: (2023-01-01)

Sex‐related pathophysiological mechanisms may be present before symptoms of HFpEF develop
著者:: B. Wong, 等
出版事項: (2025-06-01)

Sex differences in the association between nutritional status and in‐hospital mortality in HFpEF patients
著者:: Michał Czapla, 等
出版事項: (2025-08-01)

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
著者:: Paula Ketilly Nascimento Alves, 等
出版事項: (2023-11-01)

Effects of different exercise programs on the cardiorespiratory reserve in HFpEF patients: a systematic review and meta-analysis
著者:: Aristi Boulmpou, 等
出版事項: (2022-03-01)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
著者:: Michiel T.H.M. Henkens, 等
出版事項: (2022-06-01)

Mitochondrial dysfunction as a therapeutic nexus in HFpEF: therapeutic target and pharmacological advances
著者:: Tian Yue, 等
出版事項: (2025-09-01)

Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre‐capillary pulmonary hypertension
著者:: Mathias Claeys, 等
出版事項: (2023-02-01)

Schaftoside improves HFpEF through regulation the autophagy-lysosome pathway by allosterically targeting CaMKII-δ
著者:: Haiying Zhang, 等
出版事項: (2024-12-01)

Percent Predicted Peak Exercise Oxygen Pulse Provides Insights Into Ventricular-Vascular Response and Prognosticates HFpEF
著者:: Jason P. Li, MD, 等
出版事項: (2024-08-01)

Cardiometabolic Phenotype in HFpEF: Insights from Murine Models
著者:: Ekaterina Ogurtsova, 等
出版事項: (2025-03-01)

Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study
著者:: Yuki Matsuoka, 等
出版事項: (2025-02-01)

Aortic flow is abnormal in HFpEF [version 2; peer review: 2 approved]
著者:: Pankaj Garg, 等
出版事項: (2024-03-01)

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF
著者:: Paula Ketilly Nascimento Alves, 等
出版事項: (2024-03-01)

Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies
著者:: Francesca Coppi, 等
出版事項: (2025-06-01)

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF
著者:: Zhen-Yu Yang, 等
出版事項: (2025-08-01)

The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
著者:: Xiangling Duan, 等
出版事項: (2025-04-01)

Prognosis of early‐stage HFpEF in the community‐dwelling elderly: The Northern Shanghai Study
著者:: Weilun Meng, 等
出版事項: (2025-02-01)

Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study
著者:: Arif Albulushi, 等
出版事項: (2025-07-01)

Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis
著者:: Mingzhi Lin, 等
出版事項: (2025-05-01)

Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
著者:: B. Srinivas, 等
出版事項: (2024-03-01)